#Product Trends
MAMMI by Oncovision - Dedicated breast PET
MAMMI is a dedicated breast PET with unprecedented clinical resolution and fast scan time. Its imaging technology can identify small lesions, even in women with dense breasts, and assist in the diagnosis and treatment assessment of breast cancer.
MAMMI dbPET can be decisive in very early diagnosis of breast cancer and provides an extraordinary definition of active areas of heterogeneous tumors and tumor limits, even in dense breasts.
The natural prone position, with no breast compression, together with a ring configuration, provides optimum patient comfort, enhances sensitivity and detection of difficult lesions.
MAMMI is decisive in difficult lesions as the ones near the thoracic wall, in women with small breasts, multifocal and/or heterogeneous lesions, near the nipple, and in breasts with prosthesis.
High detector spatial resolution: <1.6mm. Allows the detection of small tumors with unprecedented accuracy, especially in younger women and dense breasts.
Accurate 3D real breast images with tumor activity quantification and SUV (Standardized Uptake Value), which allows image comparison.
Natural prone position with no breast compression needed.
Proven performance in assessment of therapy.
Large field of view: Ø 170 mm x 185 mm.
Fast acquisition times varying from 5-15 minutes based on breast length.
Independent acquisition and reconstruction workstations.
Strong complementary option to MRI and whole body PET